Innovation policy aims to stimulate innovation and hence firm-level productivity and growth. Here, we use data from the national innovation panel surveys in the UK and Spain over the 2004 to 2012 period to explore the effectiveness of regional, national and EU innovation support in promoting the extent of innovation activity, its novelty, and market success.
INTRODUCTION
Innovation policy typically aims to stimulate innovation and hence firm-level productivity and growth. Here, we use data from the national innovation panel surveys in the UK and Spain over the 2004 to 2012 period to explore the effectiveness of regional, national and EU innovation support in promoting the extent of innovation activity, its novelty, and market success.
The comparison of the UK and Spain is particularly interesting given the very different levels of engagement of the public sector in the innovation system in the two countries, the greater regionalisation of innovation support in Spain (Mate-Sanchez-Val and Harris 2014) , and other aspects of the business environment in the two countries such as regulation (Capelleras et al. 2008) .
In both countries the most common type of policy interventions are grants or subsidies which reduce the cost and risk of undertaking innovation. Our study adds to the existing literature on the effectiveness of such supports with one recent review, which considered the results of 77 studies of the relationship between subsidies and R&D spend, concluding that 'approximately 60 per cent of the studies find that public subsidies are complementary and thus add to private R&D investment' (Zuniga-Vicente et al. 2014, p.38) . This positive result in the evidence on R&D and innovation policy effects is reflected in other recent evidence reviews (What Works Centre for Local Growth, 2015) . We extend the existing literature on the effectiveness of innovation policy measures in three main areas. First, using a two stage modelling approach we are able to examine simultaneously the effects of firms' receipt of policy support from different sources (i.e. region, nation and EU) and identify the relative effectiveness of each type of support.
Second, by considering policy effects at both the extensive and intensive margin (i.e. the percentage of innovating firms and the percentage of innovative sales) we are able to identify which types of support impact most strongly on different innovation outcomes. And, finally, our comparative analysis provides insights into the effects of two very different innovation support regimes, and a robustness check on the effectiveness of each type of innovation support.
Our empirical analysis relates to the period 2004 to 2012, covering five waves of the UK Innovation Survey and Spanish PITEC. In England, this was a period during which the shape of innovation policy was largely determined nationally but implementation, particularly in terms of support for SMEs, was operated through the Regional Development Agencies. In other areas of the UK (Wales, Scotland and Northern Ireland) both policy and implementation were regional. Our results provide strong evidence of the differential effects of regional and national support and shed some light on the potential implications of the centralisation of UK innovation policy which has occurred since 2012 and the closure of the Regional Development Agencies (RDAs).
The study proceeds as follows. In Section 2 we provide an overview of the main justification for public support for R&D and innovation and for the contrasting impacts of regional and national support. This relates both to potential contrasts in the objectives of regional and national innovation policy, and inefficiencies introduced into the allocation of policy resources in a regional allocation system. Section 3 provides an overview of public support for innovation in the UK and Spain, emphasising the greater extent of public engagement in the innovation system in Spain, stronger Spanish regionalisation and the stronger barriers to innovation perceived by Spanish firms. Section 4 deals with data and estimation methods, and Section 5 presents our main empirical results. Section 6 concludes.
PUBLIC INTERVENTION TO SUPPORT R&D AND INNOVATION
R&D and innovation have well recognised social and private benefits (Mohnen 1996; Ceh 2009 ). Market failures related to firms' inability to appropriate the full value of these benefits have long been used to justify corrective public interventions to support firms' R&D and innovation investments (Arrow 1962; Rigby and Ramlogan 2013) . For example, one market failure which has been much discussed in the research literature, and which is repeatedly emphasised in surveys of innovative activity, is a lack of finance for innovation. Classical finance theory suggests that in perfect capital markets with no asymmetric information, investment decisions will not be dependent on capital structure (Modigliani and Miller 1958) . In practice, however, 'information problems, skewed and highly uncertain returns, and lack of collateral value likely make debt a poor substitute for equity finance'
and make funding innovation difficult (Brown, Fazzari, and Petersen 2009, p. 152) . Credit constraints for innovation may reduce the average level of innovative activity at firm level (Savignac 2008; Hottenrott and Peters 2012; Alvarez and Crespi 2015) but may also change the nature of the innovation firms undertake, away from more experimental, radical innovations to incremental and sustaining innovations (Nanda and Nicholas 2014) .
Financial barriers may also increase the likelihood of failure or the abandonment of innovative projects (Segarra, Garcıa-Quevedo, and Teruel 2013) 1 . Such effects seem likely to be stronger for newer or smaller firms (Alvarez and Crespi 2015) .
The ability of public investments in innovation to correct this type of market failure depends crucially on the allocation of support across firms. Where innovation support is allocated through a competitive process or peer or technical review it is likely to be concentrated in the strongest companies, or at least those with the strongest innovation projects 2 . Indeed, previous studies have identified eight factors linked to the receipt of public support for innovation. First, some hysteresis is evident in firms' receipt of public innovation support, hence 'a firm whose R&D activity was subsidised in the past is more likely to be subsidised again' (Zuniga-Vicente et al. 2014, p. 54 ).
This may reflect firms' awareness of the availability of public support, the commercial advantages of previous success in obtaining funding or a choice by public agencies to support firms with particular characteristics which remain the same through time and therefore lead to repeated support. 1 Mohnen, P., Palm, F. C., Van Der Loeff, S. S., & Tiwari, A .(2008) . Financial constraints and other obstacles: Are they a threat to innovation activity ? De Economist, 156, 201-214. Segarra, A., Garcıa-Quevedo, J.,and Teruel, M. (2013) . Financial constraints and the failure of innovation projects. Universitat Rovira i Virgili, wp 06-2013. 2 This type of selection criteria may maximise scheme additionality (Hottenrott and Lopes-Bento 2014) but may also reinforce rather than reduce regional disparities. . Sixth, foreign-owned firms are less likely to receive public support (Aerts and Schmidt 2008; Czarnitzki and LopesBento 2013) but there is some evidence that firms which are part of a wider enterprise group are more likely to receive public support (Karhunen and Huovari 2015) . Finally, there is some evidence that the presence of R&D staff within an enterprise is also linked positively to the receipt of subsidies in smaller Finnish firms (Karhunen and Huovari 2015) .
Compounding these firm-level influences, broader structural factors linked to both sectors and geography may also influence the probability that firms will seek and receive public innovation support 5 . For example, there is some evidence that R&D subsidies are more effective in low-tech industry sectors (Gonz´alez and Paz´o 2008; Becker and Hall 2013) . R&D subsidies may also have a disproportionately large effect on the R&D spending of firms in industries facing significant capital market limitations (Hyytinen and Toivanen 2005) . Other studies suggest the importance of distinguishing between the differential benefits of public intervention to support 'R' and 'D'
with some studies indicating higher levels of additionality from subsidies for more basic R&D activities (Czarnitzki, Hottenrott, and Thorwarth 2011; Clausen 2007) . Sectors' appropriability regime may also be important in terms of encouraging co-operative models of innovation with implications for the demand for innovative finance. Where, for example, the patent system is effective, and intellectual property regimes are transparent, co-operation is more likely reducing the financing cost to any individual enterprise (Becker 2015) .
The structure of the mechanisms through which public innovation support is allocated may also influence the extent of additionality or social benefit achieved. Where strong firms or projects are uniformly distributed across regions, for example, national and regional schemes are likely to be available to the same pool of companies. However, where the distribution of stronger firms is uneven across regions, local eligibility criteria are likely to mean that competition for support is stronger in some regions than others, leading to a potential misallocation of support. 6 Equity consideration between regions may be another mechanism which leads to a misallocation of public support.
To illustrate consider Figure 1 in which, following Haapanen, Lenihan, and
Mariani (2014) of EU Structural Funds, however, is likely to lead to similar allocation biases to regional support measures, with an emphasis on the extensive margin. In combination, we might expect EU programmes to have more modest impacts on the extensive margin than regional support and more modest effects on the intensive margin than national support.
INNOVATION POLICY IN THE UK AND SPAIN
In the UK, the governance of innovation policy is predominantly national and since 2010, and the abolition of the Regional Development Agencies, innovation policy delivery has also been largely centralised. Resource allocation is determined predominantly by national innovation competitions run by Innovate UK http://www.euraxess.es/eng/services/foreign-researchers-in-spain/guide-for-themanagement-of-the-mobility-of-the-foreign-researcher-in-spain-2014/2.researching-in-spain/2.1.-the-spanish-science-technology-and-innovationsystem. 9 In a broader econometric study of manufacturing innovation, Roper et al (2007) find no significant innovation effects from regional public support in the UK but do find a significant effect from regional support on process innovation in Catalonia. and co-ordination is driven primarily by market mechanisms, and where 'collective actors, as well as other forms of non-market coordination through chambers or cross-shareholdings, play a minor role' (Hassel 2014, p. 6 ).
Here, public innovation policy is either corrective -designed to address market failures in R&D and innovation -or creative, intended to enable leading edge innovation 10 . Spain, by contrast, is characterised as a Mixed Market Economy (or MME) (Molina and Rhodes, 2007) , or having a 'Mediterranean' mode of capitalism (Hall and Soskice 2001) , in which clientalism is more pronounced, and the state plays a compensatory role, intervening to offset competitive or financial shocks rather than facilitating firms' competitive strategies. Here too, however, corrective action might also be taken by government to address either market or innovation system failures with the aim of maximising the social benefits of innovative activity (Klette, Moen, and Griliches 2000; Martin and Scott 2000) .
Aside from the contrasting objectives and governance of innovation policy in the UK and Spain there are also significant differences in the extent of public involvement in the innovation system. Spain has an innovation system which is more strongly shaped by the public sector than the market influences which shape the innovation system in the UK. This is evident in any consideration of the profile of R&D spending and financing: the public sector is more important in both dimensions in Spain, although relative levels of R&D spend have changed markedly in recent years (Table 1 ). In particular, while levels of total R&D investment in the UK have remained broadly stable over the last decade a more cyclical pattern is evident in Spain. Prior to the great recession R&D investment in Spain increased rapidly rising from around half to two-thirds of the UK level. Since 2008, however, R&D spend in Spain has fallen sharply both in aggregate and in the business sector. The composition of R&D spend and funding has remained more stable, however, with businesses accounting for a larger proportion of R&D spend in the UK than in Spain, and government spend proportionately less important in the UK. Higher education accounts for around a quarter of all R&D spend in both countries (Table 1 , part a). As with total R&D spend, levels of business R&D spend in Spain rose prior to the recession, converging on UK levels. Since 2008, however, levels of R&D spend in both countries have declined as private innovation investment has fallen and the volume of venture capital investments declined (EU 2015) .
In terms of the funding of R&D, government is a more significant funder of R&D in Spain both in terms of total R&D and R&D undertaken by firms. Another contrast between the business environments of the UK and Spain noted in earlier studies is that the burden of regulation and legislation is greater for Spanish companies, a factor which has often been seen as having a potentially negative effect on innovative activity (Blind 2012; Epstein 2013; Ford, Steen, and Verreynne 2014; Kneller and Manderson 2012; Mazon et al. 2012; Michie and Sheehan 2003) Our dependent variables are chosen to reflect the outputs from the innovation process. In doing so, we add to the relatively few microeconometric studies to date that examine the effect of public support on innovation output (e.g. Branstetter and Sakakibara, 2002; Bérubé and Mohnen, 2009; Moretti and Wilson, 2014; Bronzini and Piselli, 2016) , compared with the much more researched effect on innovation input. First, we consider a series of binary variables indicating whether firms have undertaken product/service, process, strategic, marketing, managerial or organizational innovation over the last three years. Firms' innovation profiles vary somewhat across the two countries with UK firms more likely to engage in organizational innovation and Spanish firms more likely to be involved in product/service, strategic, managerial or marketing innovation (Table 2) .
Second, for product/service and process innovation, we consider the novelty of firms' innovation by considering whether firms have introduced any newto-the-market innovation over the previous three years. This was the case with 25 per cent of UK firms and 28 per cent of Spanish firms (Table 2) .
Finally, we consider the market success of firms' innovation activity as represented by the proportion of current sales derived from innovative products. On average UK firms derived 5.6 per cent of revenues from sales of new products or services compared to 8.0 per cent of sales by Spanish firms (Table 2 ).
In terms of public support, PITEC and the UKIS do not identify the specific support schemes from which firms benefitted, and the UKIS does not identify (Table 2) .
Our estimation strategy is shaped by the binary or truncated nature of our dependent variables and the need to be able to deal with multiple (binary) treatments which may be subject to selection bias. We adopt a two-stage approach. First, following other studies such as (Aerts and Schmidt 2008;  Czarnitzki and Lopes-Bento 2014) we estimate models for the probability that firms received regional, national or EU support for innovation Ski, where k denotes the source of innovation support:
Where FCi is a group of variables designed to reflect firms' identifiable characteristics, BARRi are variables to reflect firms' demand for public support and TARGki are variables to reflect the availability of public support in each industry and sizeband. In terms of firms' identifiable characteristics we include measures of firm size, workforce quality and whether or not a firm is an exporter. Each of these variables has previously been linked to an increased probability of receiving public innovation support (Zuniga-Vicente et al. 2014, p. 54) . The demand for support we reflect in a series of variables reflecting the finance and market barriers to firms' innovation activity. The core idea here is that firms are more likely to seek public support for innovation when they perceive stronger resource constraints 16 . Finally, to reflect policy targeting -i.e. public willingness to offer support to specific groups of firms -we include a variable reflecting the proportion of firms in each sector, region and sizeband receiving public support.
The second stage of our estimation approach is the standard innovation production function which relates innovation outputs (Ii) to inputs such as R&D, skills and the results of external knowledge search (Leiponen and Byma 2009; Leiponen 2012) . We can write:
Where FCi is a set of firm level control variables (e.g. internal versus external R&D, design, training, external knowledge acquisition, market intelligence and machinery spend), RDi is an indicator of R&D spending, XSi external knowledge search and HCi an indicator of the quality of firms' human capital.
We also include three binary treatment terms indicating whether firms received local or regional (Sri), national (Sni) or EU/international (Ssi) innovation support. We estimate these models using the conditional mixed process or CMP approach developed by Roodman (2011) . This technique allows us to instrument the three binary treatment innovation support terms using simplified versions of the selection models described earlier. Our estimation sample is based on pooled data from five waves of the UKIS and PITEC innovation surveys, an approach we adopt to allow robust subsample estimates. To allow for sectoral and temporal heterogeneity we also 16 In the PITEC and UKIS data sets firms are asked to identify whether these factors are a major, medium, minor or no constraint on their innovation activity. We translate these into dummy variables which take value 1 when each factor is a major or medium constraint.
include sector dummies at the 2-digit level and wave dummies in each model.
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EMPIRICAL RESULTS
We initially investigate the determinants of the probability of receiving public support for innovation with the expectation that as a result of competitive or peer review-based allocation mechanisms the receipt of regional, national and EU level support will be associated with stronger internal resources (Aerts and Schmidt 2008; Czarnitzki and Lopes-Bento 2013; Karhunen and Huovari 2015) . Probit models for the probability of receiving support in the UK and Spain are reported in Tables 3 and 4 . All models include industry and time dummy variables intended to control for sectoral differences in innovation propensity and appropriability regimes (Becker 2015) . Workforce quality, an indicator of scale (employment), and exporting are positively associated with the receipt of innovation support in both the UK (Table 3) and Spain (Table 4 ) (Aerts and Schmidt 2008; Czarnitzki and Lopes-Bento 2013) . Firms experiencing finance constraints for innovation and uncertain demand are also more likely to receive each type of public support although these effects are more sizable in terms of regional and national rather than EU support (Tables 3 and 4 ) (Hyytinen and Toivanen 2005) . Targeting effects also prove important with penetration rates for each type of public support positively associated with individual firms' receipt of such support. In both Spain and the UK these penetration rate effects are strongest for regional innovation support (Tables 3 and 4) . Here, our results are largely consistent with those of previous studies which have considered the correlates of the receipt of public innovation support.
In terms of the impact of public support on the extensive margin, i.e. the probability of innovating, our expectation is that this will be most strongly linked to regional support due to potential misallocation effects and the compensatory tendency of regional support measures. This is the focus of Tables 5 (UK) and 6 (Spain). We find that regional or local support initiatives are positively associated with the probability of undertaking process, organisational, strategy, management and marketing innovation in the UK (Table 5) and product, organisational, management and marketing innovation in Spain (Table 6 ). In each case, effect sizes are larger in Spain perhaps due to the greater influence of public sector support in the Spanish innovation system (Mate-Sanchez-Val and Harris 2014). For example, regional support in Spain is associated with a 33 per cent increase in the probability of undertaking organisational innovation compared to 11 per cent in the UK (Tables 5 and 6 ). The consistently positive and significant effects associated with regional support also contrast with much weaker links between national and EU policy support and the probability of innovating in both countries (Tables 5 and 6) . Notably, however, in both the UK and Spain we do find a positive association between the receipt of national innovation support and the probability of product or service innovation. One possibility is that this is linked to the competitive nature of much national innovation support which may favour product or service changes over more organisational changes. Again, however, the scale of this effect (21 per cent)
is notably larger in Spain than in the UK (8 per cent) again reflecting the greater influence of public sector support in the Spanish innovation system (Mate-Sanchez-Val and Harris 2014). In terms of EU support we find a contrasting picture with weak negative associations with the probability of process and marketing innovation in the UK (Table 5 ) and sizable positive associations with strategic and marketing innovation in Spain (Table 6) .
Our results suggest the differential effects of regional, national and EU support at the extensive margin: regional initiatives support broadly-based innovation, while national initiatives impact only on the probability of product or service innovation. Other control variables impact largely as anticipated.
The probability of innovation -of all types -is positively linked to scale, design spend (Filipetti 2010) , exporting (Love and Roper 2015) , external partnerships (Moon 2011) , in house R&D (Love and S 2001; Love and Roper 2005 ) and innovation related investment in external knowledge, market intelligence and equipment in both the UK and Spain.
While the extent of innovation activity in a population of firms may be important in generating potential market advantages and externalities it is arguably more important to be generating new-to-the-market innovations and increased innovative sales. New-to-the-market innovations provide the basis for creative destruction, while innovative sales provide an indication of the market success of an innovation and have been linked in previous studies to future productivity and sales growth. Both are examined in Table   7 . Again, we anticipate that public support of all types will have a positive effect on both the novelty and market success of innovation, however, due to the combination of competitive allocation and a lack of any regionalised bias we anticipate stronger national policy effects. In both the UK and Spain -as anticipated -we find a strong positive association between national innovation support and new-to-the-market innovation and a weaker (or negative) regional policy link (Table 7) . Again the effect size of national innovation support is larger in Spain (26 per cent) than in the UK (8 per cent).
EU support has little effect in the UK but has a strong positive association with new-to-the-market innovation in Spain. In terms of the impact of public support on innovative sales we see some contrasts between the UK and Spanish results. In the UK, national support influences the novelty of innovation -again perhaps linked to the competitive allocation mechanisms -but only regionalised support influences the market success of innovation.
In Spain both national and regional support influence both novelty and innovation success with stronger national policy effects. Again, control variables impact largely as anticipated (Table 7) . EU support again has little effect on innovative sales in the UK but has a large and significant influence in Spain. Table 8 provides a symbolic summary of our estimation results focussing on the effects of regional, national and EU support on innovation outcomes. Our analysis suggests four key findings. First, at the extensive margin, regional support seems most influential in both the UK and Spain for process and organisational innovation. This may reflect both the regionalised allocation of support which means that in some cases weaker firms -and potentially non-innovators -are supported as well as the potential compensatory objectives of regional policies. Second, for both the UK and Spain -and by contrast with other types of innovation -national innovation support is associated with a higher probability of product or service innovation. This may reflect the orientation of national competitions for innovation support towards product/service innovations rather than organisational innovation. -has yet to be established. A binary variable taking value 1 if the firm has introduced any new or significantly improved process for producing or supplying goods or services over the last three years. Organisational innovation (0/1) A binary variable taking value 1 if the firm has implemented major changes to organisational structure (e.g. cross-site or team-working) over the last three years. Strategic innovation (0/1) A binary variable taking value 1 if the firm has implemented a new or significantly changed corporate strategy over the last three years Management innovation (0/1) A binary variable taking value 1 if the firm has implemented new management techniques (e.g. just in time) over the last three years. Marketing innovation (0/1) A binary variable taking value 1 if the firm has implemented new marketing concepts or strategies over the last three years. New to market product innovation (0/1) A binary variable taking value 1 if the firm has introduced any new or significantly improved process for producing or supplying goods or services over the last three years. New to market process innovation (0/1) A binary variable taking value 1 if the firm has introduced any new or significantly improved process for producing or supplying goods or services over the last three years. % of innovative sales -new products Percentage of sales derived from products or services newly introduced over the last three years. % of innovative sales -new and improved products Percentage of sales derived from products or services newly introduced or significantly improved over the last three years.
CONCLUSIONS
Policy indicators
Regional or local support (0/1), National innovation support (0/1), EU innovation support (0/1) A binary variable taking value 1 if the firm received public financial support for innovation activities from local or regional authorities/ central government/ EU institutions or programmes over the last three years.
Explanatory variables
Log (employment)
Employment three years prior to survey date (log)
Design spend (0/1), In house R&D (0/1), External R&D (0/1), Training spend (0/1), Acquisition of external knowledge (0/1), Acquisition of market intelligence (0/1), Machinery (0/1).
Binary variables taking value 1 if the firm invested in design etc. as part of its innovation activities over the last three years.
Science and engineering graduates (%), Other graduates (%)
The proportion of the firm's workforce who are science and engineering/other graduates (UK only) Superior education graduates (%)
The proportion of the firm's workforce who are graduates (Spain only) Exporting firm (0/1) A binary variable taking value 1 if the firm is exporting
Number of innovation partners (0-7) A count variable indicating the number of different partner types with which the firm is collaborating for innovation.
